Saint Luke’s Clinical Trial Shows Improvements in Patients with Common Genetic Heart Condition Saint Luke’s Mid America Heart Institute announced the results of a clinical trial that will impact patient care and improve quality of life for patients suffering from the most common genetic heart condition, called hypertrophic cardiomyopathy (HCM).